Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.hcgoncology.com | |
Market Cap | 3,866.09 Cr. | |
Enterprise Value(EV) | 4,131.84 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.90 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 46.72 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 63.34 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 4.41 | Calculated using Price: 279.45 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 13.91 Cr. | 139,092,937 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand. |
1 Day |
|
-1.50% |
1 Week |
|
-3.54% |
1 Month |
|
-2.83% |
3 Month |
|
-2.34% |
6 Month |
|
+3.77% |
1 Year |
|
+14.48% |
2 Year |
|
+84.52% |
5 Year |
|
-11.07% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -15.10 | 1.75 | 0.64 | 5.38 | 3.71 | -6.48 | -29.68 | -43.32 | 5.16 | |
Return on Capital Employed (%) | -0.71 | 6.41 | 5.60 | 7.22 | 7.59 | 3.46 | 1.65 | -9.66 | 15.17 | |
Return on Assets (%) | -5.91 | 0.64 | 0.25 | 2.06 | 1.29 | -2.03 | -6.51 | -10.46 | 1.85 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 263 | 279 | 426 | 433 | 515 | 477 | 381 | 697 | 870 | 881 | |
Non Curr. Liab. | 257 | 279 | 306 | 354 | 483 | 557 | 1,232 | 822 | 860 | 867 | |
Curr. Liab. | 149 | 187 | 263 | 366 | 359 | 547 | 576 | 465 | 470 | 510 | |
Minority Int. | 18 | 25 | 33 | 57 | 64 | 46 | 39 | 17 | 13 | 9 | |
Equity & Liab. | 688 | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,266 | |
Non Curr. Assets | 578 | 648 | 800 | 966 | 1,200 | 1,354 | 1,923 | 1,566 | 1,711 | 1,738 | |
Curr. Assets | 109 | 122 | 227 | 244 | 220 | 273 | 304 | 435 | 502 | 528 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 688 | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,266 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 450 | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,551 | |
Other Income | 5 | 5 | 4 | 10 | 19 | 10 | 10 | 21 | 16 | 11 | |
Total Income | 455 | 524 | 588 | 710 | 848 | 986 | 1,103 | 1,030 | 1,410 | 1,562 | |
Total Expenditure | -413 | -443 | -499 | -595 | -716 | -853 | -923 | -887 | -1,160 | -1,279 | |
PBIDT | 42 | 81 | 89 | 115 | 132 | 133 | 179 | 144 | 251 | 283 | |
Interest | -32 | -34 | -38 | -23 | -42 | -70 | -138 | -119 | -98 | -99 | |
Depreciation | -36 | -39 | -44 | -57 | -71 | -85 | -148 | -159 | -158 | -163 | |
Taxation | -5 | 2 | 2 | -12 | -10 | 3 | -6 | 8 | -49 | -15 | |
Exceptional Items | -10 | -5 | -6 | 11 | -93 | 95 | -46 | ||||
PAT | -42 | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | -40 | |
Minority Interest | -2 | -4 | -4 | -1 | 4 | 6 | 19 | 28 | 15 | 13 | |
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -44 | 1 | -1 | 22 | 21 | -25 | -107 | -193 | 54 | -26 | |
Adjusted EPS | -6 | 0 | 0 | 3 | 2 | -3 | -12 | -15 | 4 | -2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 29 | 50 | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | |
Cash Fr. Inv. | -100 | -58 | -80 | -204 | -210 | -282 | -238 | -101 | -171 | 125 | |
Cash Fr. Finan. | 66 | 23 | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | |
Net Change | -6 | 15 | 2 | 85 | -29 | -23 | -56 | -30 | 62 | 190 | |
Cash & Cash Eqvt | 11 | 25 | 25 | 80 | 51 | 27 | -29 | -59 | 3 | 193 |
Wed, 25 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting And Earnings Call Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve Intimation of Meeting of Board of Directors and Earnings call to discuss the Unaudited Financial Results of HealthCare Global Enterprises Limited (the Company). |
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018. |
Mon, 12 Dec 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of schedule of investor meeting |
Mon, 30 Jan 2023 |
|
|
|
|
|